U.S. Nucleic Acid Labeling Market Size & Outlook, 2019-2027
U.S. nucleic acid labeling market, 2016-2027 (US$M)
Related Markets
U.S. nucleic acid labeling market highlights
- The U.S. nucleic acid labeling market generated a revenue of USD 501.7 million in 2019 and is expected to reach USD 927.6 million by 2027.
- The U.S. market is expected to grow at a CAGR of 8% from 2020 to 2027.
- In terms of segment, reagents was the largest revenue generating product in 2019.
- Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Nucleic acid labeling market data book summary
| Market revenue in 2019 | USD 501.7 million |
| Market revenue in 2027 | USD 927.6 million |
| Growth rate | 8% (CAGR from 2019 to 2027) |
| Largest segment | Reagents |
| Fastest growing segment | Kits |
| Historical data | 2016 - 2018 |
| Base year | 2019 |
| Forecast period | 2020 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits, Reagents, Instruments |
| Key market players worldwide | PerkinElmer, Roche, GE Aerospace, Thermo Fisher Scientific Inc, Promega, New England Biolabs, Enzo Biochem Inc, Vector Informatik, Merck KGaA, Agilent Technologies Inc, Agilent Technologies |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.6% of the global nucleic acid labeling market in 2019.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In North America, U.S. nucleic acid labeling market is projected to lead the regional market in terms of revenue in 2027.
- Canada is the fastest growing regional market in North America and is projected to reach USD 292.2 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleic Acid Labeling Market Scope
Nucleic Acid Labeling Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. nucleic acid labeling market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleic acid labeling market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 43.13% in 2019. Horizon Databook has segmented the U.S. nucleic acid labeling market based on kits, reagents, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
- U.S. Nucleic Acid Labeling Product Outlook (Revenue, USD Million, 2016-2027)
- Kits
- Reagents
- Instruments
- U.S. Nucleic Acid Labeling Labeling Type Outlook (Revenue, USD Million, 2016-2027)
- Radioisotope/Radioactive Labels
- Non-radioactive Labels
- U.S. Nucleic Acid Labeling Method Outlook (Revenue, USD Million, 2016-2027)
- Enzyme-based
- PCR
- 5' end labeling
- 3' end labeling
- Others
- Chemical-based
- Conjugation
- Photoreaction
- Enzyme-based
- U.S. Nucleic Acid Labeling Application Outlook (Revenue, USD Million, 2016-2027)
- Oligonucleotide Labeling
- In-situ Hybridization
- Southern & Northern Blotting
- Cellular Localization
- Others
- U.S. Nucleic Acid Labeling Sector Outlook (Revenue, USD Million, 2016-2027)
- Diagnostics
- Research
- Therapeutics
Reasons to subscribe to U.S. nucleic acid labeling market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. nucleic acid labeling market databook
-
Our clientele includes a mix of nucleic acid labeling market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. nucleic acid labeling market, including forecasts for subscribers. This country databook contains high-level insights into U.S. nucleic acid labeling market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. nucleic acid labeling market size, by product, 2016-2027 (US$M)
U.S. Nucleic Acid Labeling Market Share, 2019 & 2027 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
